Norgine, a leading European specialist pharmaceutical company, has announced the findings of its study. This study highlights the need to increase quality conversations and informed shared decision-making between expectant mothers and their healthcare professionals when it comes to induction of labour (IoL).
IoL is one of the most frequently performed obstetric interventions globally. The survey findings suggest that obstetricians and midwives make a difference by actively enhancing the dialogue with expectant mothers to support the collaborative decision-making process. The study demonstrates a clear need to increase the provision of more detailed and timely information about IoL to expectant mothers, to further support their informed choices about IoL.
Induction of labour is a very common procedure in pregnancy. Expectant mothers need to feel actively involved in their care and empowered to hold in-depth conversations with healthcare professionals. Providing comprehensive information about the IoL options available and considering women’s preferences are important to enable mothers to make informed choices of what’s best for them and their baby.
Dr David Gillen, Chief Medical Officer of Norgine, said: “This study highlights an unmet need for information and enhanced dialogue around the induction of labour. Shared decision-making in healthcare is vital and we should make every effort to support healthcare professionals with better tools to facilitate collaborative decisions with expectant mothers.”